Clinical Research Directory
Browse clinical research sites, groups, and studies.
Verapamil for Neuroprotection in Stroke
Sponsor: Global Neurosciences Institute
Summary
The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery from stroke. Recruitment is limited to patients that have received mechanical thrombectomy as standard of care.
Official title: Intraarterial Verapamil for Neuroprotection in Ischemic Stroke
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2017-04-20
Completion Date
2026-12
Last Updated
2025-01-17
Healthy Volunteers
No
Conditions
Interventions
10 mg Intra-arterial Verapamil
Intra-arterial delivery of verapamil following mechanical thrombectomy procedure will be administered at a randomized dose of 10 mg or 20 mg to consenting patients.
20 mg Intra-arterial Verapamil
Intra-arterial delivery of verapamil following mechanical thrombectomy procedure will be administered at a randomized dose of 10 mg or 20 mg to consenting patients.
Locations (3)
AtlantiCare Regional Medical Center
Atlantic City, New Jersey, United States
St Mary Medical Center
Langhorne, Pennsylvania, United States
Crozer Chester Medical Center
Upland, Pennsylvania, United States